Tilray Inc (NASDAQ:TLRY) Shares Sold by Signaturefd LLC

Signaturefd LLC lowered its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 41.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 114,696 shares of the company’s stock after selling 81,889 shares during the period. Signaturefd LLC’s holdings in Tilray were worth $153,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bank of Montreal Can raised its position in shares of Tilray by 0.3% in the third quarter. Bank of Montreal Can now owns 2,176,506 shares of the company’s stock valued at $3,787,000 after buying an additional 7,406 shares during the last quarter. State Street Corp raised its position in shares of Tilray by 4.7% in the third quarter. State Street Corp now owns 1,961,338 shares of the company’s stock valued at $3,452,000 after buying an additional 88,079 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of Tilray by 1,314.1% in the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after buying an additional 1,690,827 shares during the last quarter. Swiss National Bank raised its position in shares of Tilray by 10.2% in the fourth quarter. Swiss National Bank now owns 1,776,638 shares of the company’s stock valued at $2,363,000 after buying an additional 164,600 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Tilray by 6.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company’s stock valued at $2,953,000 after buying an additional 107,530 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Price Performance

Tilray stock opened at $0.65 on Friday. Tilray Inc has a 1 year low of $0.58 and a 1 year high of $2.97. The firm has a 50 day moving average price of $0.91 and a 200 day moving average price of $1.30. The company has a market cap of $609.48 million, a price-to-earnings ratio of -2.17 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54.

Tilray (NASDAQ:TLRY) last released its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The company had revenue of $210.90 million during the quarter, compared to analysts’ expectations of $216.34 million. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. Sell-side analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group boosted their price objective on shares of Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $2.70.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.